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Abstract
Cardiovascular disease (CYD) is the single leading cause o f death and a 
significant cause of morbidity o f American women. Despite years of research and 
compelling data indicating that CYD is largely preventable, alarming trends in the 
prevalence and management o f risk factors in women continue to occur. In 2005, the 
estimated direct and indirect cost o f CYD was $393.5 billion (American Heart 
Association [AHA], 2005). Despite the fact that CYD kills more women per year than the 
next six causes of death combined; only 13% of women consider CYD to be their 
greatest health risk (AHA, 2005). Educating the healthcare provider, as well as the 
patient, is key to women adopting the necessary lifestyle modifications. According to 
Mosca et al. (1999), a 1995 Gallup Survey demonstrated that four of five women and 
32% o f their primary care physicians did not know that CYD was the leading killer o f 
American women.
The purpose of this Evidence Based Practice (EBP) project was to develop an 
Advanced Practice Nurse (APN) knowledgebase regarding cardiovascular disease in 
postmenopausal women. A Boolean computer search of healthcare literature utilizing
CINAHL, MEDLINE, and the COCHRANE Library was conducted for this review. The 
research questions asked were as follows:
1. What is the level of nursing knowledge regarding CVD in postmenopausal women?
2. What are the Evidence-Based Practice guidelines for the cardiovascular healthcare of 
postmenopausal women?
3. According to the literature, what is the role o f the Nurse Practitioner (NP) in the 
management o f CVD in postmenopausal women?
Nola J. Pender’s Health Promotion Model served as the theoretical foundation for 
this clinical project and guided the systematic review through data collection of the 
healthcare literature. A knowledgebase of findings was developed according to the 
template developed by Davidson (2003). EBP guidelines regarding the cardiovascular 
healthcare o f postmenopausal women were presented. Implications and recommendations 
for nursing theory, nursing research, advanced nursing practice, nurse practitioner 
education, and health policy are encouraged from the ideas explored.
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CHAPTER I 
Dimensions of the Problem
Coronary vascular disease (CVD) is the single leading cause of death and a 
significant cause of morbidity of American women. Despite years o f research and 
compelling data indicating that CVD is largely preventable, alarming trends in the 
prevalence and management of risk factors in women continue to occur. These risk 
factors are well documented and their management and treatment are relatively cost- 
effective (Mosca, et al.). In 2005 the estimated direct and indirect cost o f CVD is $393.5 
billion (American Heart Association [AHA], 2005).
AHA reports that despite the fact that CVD kills more women per year than the 
next six causes o f death combined; only 13% of women consider CVD to be their 
greatest health risk A 1995 Gallup Survey demonstrated that four o f five women and 32% 
of primary care physicians did not know that CVD was the leading cause of death for 
women (Mosca, et al.). Educating the healthcare provider as well as the patient is key to 
women adhering to health promoting activities. Research done in England by Campbell 
et al., (1998) revealed that patients showed more compliance with their disease 
management regimen when there was a united focus o f both patient and healthcare 
provider.
Problem Statement
AHA reports that the number one fear o f death in women continues to be from 
cancer. The reality is that in 2002, the death rates were 25.6 for breast cancer and 41.6 for 
lung cancer. These statistics are compared to 273.4 for women who died from CVD that 
same year. One in 30 female deaths was from breast cancer, while one in 2.5 was from
CVD (AHA, 2005).
Cardiovascular disease is the most common cause of death o f  both men and 
women and is recognized as having distinct gender-specific features. Many o f these 
features are credited for the discrepancies in evaluation and treatment o f CVD in women. 
On average, coronary artery disease presents 10 years later in women than in men. The 
median age for myocardial infarctions (MI) is approximately 20 years older in women 
than in their male counterparts (Tecce, Dasgupta & Doherty, 2003). The reason for this 
delay is not completely understood, but it appears to be due to a cardioprotective benefit 
o f endogenous hormones prior to menopause. The incidence o f CVD in young women 
remains low, but following menopause, women catch up to men quickly, and within a 
decade after menopause, the prevalence of coronary disease is nearly equal. The U.S. 
Census estimates that there will be 40 million Americans age 65 and older in 2010 (AHA, 
2005). With longer life-expectancies, women routinely live one-third o f their lives after 
menopause therefore making CVD a significant issue for women.
Statement o f  Purpose 
The purpose of this project was to review and explore literature related to the 
current level o f nursing knowledge in the occurrence and management of CVD in the 
postmenopausal woman (PMW) and to further determine applicable evidence-based 
practice guidelines as a focus for future research.
Significance o f  the Study 
The current level of healthcare knowledge regarding CVD and postmenopausal 
women is increasing now that CVD is recognized as the single leading cause of death in 
women over age 50 in the U.S. Research results vary significantly regarding gender
differences and the cardioprotective effects o f hormone replacement therapy (HRT) 
among other issues. Until these studies are published, our focus as healthcare providers 
should be on the treatment o f risk factors previously proven to favorably impact 
cardiovascular morbidity and mortality. A  computer search o f CINAHL, MEDLINE, and 
COCHRANE revealed the following results:
Table 1
Summary of Literature Searches_______________________________________________ _
Search Terms Number o f Citations Database
CVD, PMW, Nurse Practitioner (NP) 0 CINAHL
1 MEDLINE
0 COCHRANE
CVD and PMW 217 CINAHL
35 MEDLINE
2 COCHRANE
CVD and NP 13 CINAHL
34 MEDLINE
9 COCHRANE
PMW and NP 1 CINAHL
7 MEDLINE
2 COCHRANE
CVD and Pender 9 CINAHL
0 MEDLINE
58 COCHRANE
PMW and Pender I CINAHL
0 MEDLINE
27 COCHRANE
NP and Pender 2 CINAHL
0 MEDLINE
10 COCHRANE
Note. CINAHL = Cumulative Index to Nursing and Allied Health Literature, MEDLINE 
= Medical Literature Online, COCHRANE = Cochrane Library (Cochrane Database o f 
Systematic Review, Cochrane Database o f Abstracts o f Reviews o f Evidence, and 
Cochrane Clinical Trials Register)
The clinical significance of this study is to utilize the results to provide cost- 
effective and high quality care to postmenopausal Avomen in the treatment and prevention 
o f CVD. A woman’s cardiovascular risk sky rockets once she has passed menopause. 
This causes women to move from low risk to extremely high risk for cardiovascular 
events in just over a decade.
Theoretical Foundation
Nola J. Pender’s Health Promotion Model (HPM) provided the theoretical 
foundation for this study. Pender’s theory identifies the variables that lead to adherence 
or rejection of health promoting activities. Her theory contributes a nursing solution to 
health policy and healthcare reform by providing a means for understanding how 
consumers can be motivated to attain personal health. The model is an attempt to depict 
the multifaceted nature o f persons interacting with the environment as they pursue health. 
The HPM has a competence or approach-oriented focus. Health promotion is motivated 
by the desire to increase well being and actualize human potential.
The HPM has been formulated through induction by use o f existing research to 
form a pattern o f knowledge about health behavior. The HPM is a conceptual model that 
was formulated with the goal o f integrating what is known about health-promoting 
behavior to generate questions for further testing. This model provides a framework for 
seeing how the results o f previous research fit together more clearly and how concepts 
can be manipulated for further study. Pender’s major assumptions reflect the behavioral 
science perspective and emphasize the active role o f the patient for managing health 
behaviors by modifying the environmental context. Pender’s theoretical assertions 
derived from the model are listed in the table below:
Table 2
Pender’s Theoretical Assertions
“ 1. Prior behavior and inherited and acquired characteristics influence beliefs, affect, and 
enactment o f health-promoting behavior.
2. Persons commit to engaging in behaviors from which they anticipate deriving 
personally valued benefits.
3. Perceived barriers can constrain commitment to action, mediator o f behavior, and 
actual behavior.
4. Perceived competence or self-efficacy to execute a given behavior increases the 
likelihood o f commitment to action and actual performance o f behavior.
5. Greater perceived self-efficacy results in fewer perceived barriers to specific health 
behavior.
6. Positive affect toward a behavior results in greater perceived self-efficacy, which can, 
m turn, result in increased positive affect.
7. When positive emotions or affect are associated with a behavior, the probability o f 
com m itm ent and action are increased.
8. Persons are more likely to commit to and engage in health-promoting behaviors when 
significant others model the behavior, expect the behavior to occur, and provide 
assistance and support to enable the behavior.
9. Families, peers, and healthcare providers are important sources o f  interpersonal 
influence that can increase or decrease commitment to and engagement in health- 
promoting behavior.
10. Situational influences in the external environment can increase or decrease 
commitment to or participation in health-promoting behavior.
11. The greater the commitment to a specific plan o f action, the more likely health- 
promoting behaviors are to be maintained over time.
12. Commitment to a plan o f action is less likely to result in the desired behavior when 
competing demands over which persons have little control require immediate 
attention.
13. Commitment to a plan o f action is less Ukely to result in the desired behavior when 
other actions are more attractive and thus preferred over the target behavior.
14. Persons can modify cognitions, affect, and the interpersonal and physical 
environments to create incentives for health actions.”
Toomey & Alligood, 2002 (pp. 630-631)
Definition o f  Terms
For the purpose of this study the following terms were defined:
Cardiovascular Disease
Theoretical All diseases affecting the heart and blood vessels. This includes 
arteriosclerosis, coronary artery disease, heart valve disease, arrhythmias, heart failure, 
hypertension, orthostatic hypotension, shock, endocarditis, diseases o f the aorta and its 
branches, disorders o f the peripheral vascular system, and congenital heart disease.
Operational. Diseases of the heart and/or blood vessels including acute events 
such as myocardial infarctions and strokes as woil as chronic conditions like 
hypertension.
Postmenopausal women
Theoretical. Any woman who has been without menses for at least 12 
consecutive months.
Operational Any woman whose ovaries no longer produce estrogen either 
naturally or due to surgical removal.
Nurse Practitioner
Theoretical A registered nurse with additional education and experience, a 
masters degree, and is licensed to practice as an advanced practice nurse who assesses, 
diagnoses, treats, and manages both acute and chronic routine illnesses.
Operational. An advanced practice nurse, licensed and working as a healthcare 
provider.
Research Questions
For the purposes of this study the following research questions were generated:
1. What is the level o f nursing knowledge regarding cardiovascular disease in 
postmenopausal women?
2. What are the evidence-based practice guidelines for cardiovascular healthcare of 
postmenopausal women?
3. According to the literature, what is the role o f the nurse practitioner in the management 
o f cardiovascular disease in postmenopausal women?
Delimitations
Literature for the purposes of this integrative literature review will be delimited to
the following:
1. Literature which pertains to cardiovascular disease and postmenopausal women.
2. Literature that is available in the English language.
3. Literature that is available through CINAHL, MEDLINE, or the COCHRANE Library, 
or those referenced by articles from these sources and retrieved via other databases 
accessible through the Fant Library at the Mississippi University for Women.
Limitations
For the purpose of this investigation, the following limitations were identified:
1. Despite the vast amount of information found on cardiovascular disease and 
postmenopausal women, very little research addresses the contribution of the nurse 
practitioner.
2. The sample size o f selected references.




Cardiovascular disease in postmenopausal women is clearly a significant issue 
both due to the mortality and morbidity o f the disease, as well as to the prevalence in the 
U.S. Vast differences exist in the occurrence, presentation, diagnosis and treatment o f 
CVD in women and in men. Until menopause, women have a very low risk o f developing 
CVD. Within a decade o f reaching menopause, women have matched and surpassed the 
risks of their male counterpart.
The money spent annually on treatment o f CVD could instead be used for 
prevention of the devastating CVD events. The obvious focus must be on the modifiable 
risk factors for the prevention and treatment o f CVD. Pender’s Health Promotion Model 
emphasizes the importance of individual assessment o f the factors believed to influence 
health behavior changes and therefore serves as this study’s theoretical foundation.
CHAPTER II 
Review o f Literature
For the purposes of this investigation, data-based manuscripts were reviewed and 
critiqued using a knowledgebase template for cardiovascular disease in postmenopausal 
women (see Appendix A). Literature reviewed regarding cardiovascular disease in 
postmenopausal women totaled 13 manuscripts, which represented reviews of another 
611 references. In this chapter, an overview o f each study variable is presented as it has 
emerged from the developing knowledgebase.
An Overview o f  the Healthcare Literature 
Related to Cardiovascular Disease in Postmenopausal Women
According to the American Heart Association (Brown et al., 2005), a 
retrospective analysis o f 8,928 subjects revealed significant data related to cardiovascular 
disease, postmenopausal women and the use o f aspirin. The researchers found that 
women taking aspirin had a significantly lower risk o f cardiovascular death as well as 
death from all causes, compared to women who did not take aspirin. Eighty-one mg 
aspirin was equally as effective as 325 mg in this population. The strength o f this data- 
based research by Brown et al. was the large sample size, while the weakness was that no 
cause-and-effect could be demonstrated since this was not a randomized trial. The 
conclusion could not be made that aspirin actually caused the reduction in the 
cardiovascular events. This study does, however, provide the foundation for further 
research on the benefits o f aspirin therapy in postmenopausal women.
In a systematic literature review by Anderson and Kessenich (2001), indexed in 
CINAHL, various concepts were reviewed. In this data-based article the authors reviewed
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the concepts o f cardiovascular disease, women, gender differences, risk factors, signs and 
symptoms, and clinical management. The research included 42 references. Women were 
found to differ from men in occurrence, presentation, diagnosis, treatment, and outcomes 
o f cardiovascular disease. Education o f both women and their healthcare providers is 
essential in improving patient outcomes. The strength o f the review is the large number 
o f references reviewed. A weakness was identified in the design of the study in that the 
methodologies o f cited references varied widely. This literature selection methodology 
allows for possibly skewed data. The study does, however, provide the opportunity for 
further research on cardiovascular disease in postmenopausal women
According to a manuscript by Campbell et al. (1998), indexed in MEDLINE, the 
concepts o f cardiovascular disease, secondary prevention, nurse led clinics and primary 
care were explored. This data-based article reports a randomized clinical trial that 
involved 1,173 subjects. Twenty-one references were cited in this research. The large 
sample size was a strength of the study, while the fact that only a minority of the subjects 
were female represents a concerning weakness. The relevancy o f the results for 
postmenopausal women is questionable since so few were involved in the study. The 
possibility of self-report bias is an additional weakness. The key finding of this study 
revealed that nurse led clinics in primary care can improve both medical and lifestyle 
components o f secondary prevention effectively. Further research involving 
postmenopausal women is indicated.
In a data-based study by Cassidy (2005), indexed in MEDLINE, a number of 
concepts were explored. This systematic literature review examined menopause, nutrition 
and diet, and women’s health. The 38 references that were cited included very few
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American women. The excellent teaching information included for postmenopausal 
women with cardiovascular disease was a major strength of the study. The studies 
indicated that many of the diseases associated with aging could actually be prevented or 
minimized by modest changes in dietary intake and physical activity. These results are 
encouraging and provide a foundation for further research involving American women to 
verify findings in that population.
According to a systematic literature review o f randomized double-blind trials by 
Farquhar, Maijoribanks, Lethaby, Lamberts, and Suckling (2005), indexed in the 
Cochrane Library, a number o f articles were reviewed. The authors explored 
perimenopausal women, postmenopausal women, and hormone replacement therapy in 
this data-based study. An overwhelming strength o f the study is that 35,089 subjects were 
involved. The weakness lies in the merged data from the 66 references utilized and the 
fact that this literature selection methodology could account for skewed findings. The key 
findings include that combined hormone replacement therapy significantly increased the 
risk of deep vein thrombosis, stroke, breast cancer, and gallbladder disease. Estrogen only 
therapy also significantly increased the risk o f stroke and gallbladder disease. Hormone 
replacement therapy should not be used for the routine management o f chronic disease. 
The only statistically significant benefits of hormone replacement therapy were decreased 
incidence of fractures and colon cancer with long-term use. Relief o f vasomotor 
symptoms is currently the only reason to prescribe hormone replacement. The risk and 
benefits must be weighed carefully by the healthcare provider and discussed with the 
patient. More research is definitely needed on the safety o f hormone replacement therapy.
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In a data-based manuscript by Jackson, Aarabi, and Wallis (2005), indexed in the 
Cochrane Library, a number of studies were reviewed. The authors explored the concepts 
o f cardiovascular disease, aspirin, adverse effects, and benefits. This meta-analysis of 
blinded studies, open studies with blinded end-point assessment, randomized control 
trials, and cluster randomized trials reviewed 26 articles. The strength of this study is the 
large sample size. Unfortunately, the weakness is reflected in the lack of heterogeneity of 
trials therefore causing a threat o f skewed data. The findings reflect a clear reduction in 
mortality and non-fatal cardiovascular disease events among those with prior myocardial 
infarction (MI), stroke, bypass surgery, angioplasty, peripheral vascular disease, or 
angina with aspirin use. The Food and Drug Administration (FDA) also extended the use 
o f aspirin for use with acute evolving Mis and to wider categories o f  secondary 
prevention of cardiovascular events. Primary cardiovascular events were reduced by 
aspirin use, also. Aspirin has serious possible side effects o f gastrointestinal bleeding and 
hemorrhagic strokes. The opportunity for further research qualifying both the precise 
benefits and risks o f aspirin therapy in primary prevention is clear.
According to a data-based study by Moustapha and Robinson (1999), indexed in 
CINAHL, another independent risk factor for atherosclerosis in the elderly has been 
identified. This meta-analysis reviewed 30 references regarding the concepts of 
homocysteine, cardiovascular risk factors, older populations, and menopause. The 
strength o f this research is the identification o f a high plasma level o f total homocysteine 
concentration as an independent risk factor for atherosclerosis. The lack of heterogeneity 
of studies was identified as a weakness of the research. The key findings include the 
complexity o f this elevated homocysteine level are likely related to suboptimal vitamin
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status and kidney dysfunction. Pending results from further studies, only high risk 
patients should be screened for this potential marker. Treatment includes dietary changes, 
or if unsuccessful, then supplementation with folic acid and vitamin B12. The threat o f 
this study is the lack o f clinical trials to identify the mechanism, if  any, by which 
increased homocysteine may cause vascular damage. This provides an excellent 
foundation for further research on the usefulness o f this newly identified inflammatory 
marker.
In an observational analysis by Parsons et al. (2004), indexed in MEDLINE, 
several concepts were explored. The authors o f this data-based article cited 36 references 
and reviewed the concepts of postmenopausal women, acute coronary syndromes, and 
hormone replacement therapy. The large number o f postmenopausal women (n = 4,029) 
studied was identified as a strength o f this study. A significant weakness, however, is that 
the observational analysis was conducted in a database collected for other purposes, 
therefore preventing the proof o f a causal relationship between hormone replacement 
therapy and outcomes. The key findings revealed that overall hormone use was low 
among women with acute cardiac syndrome and varied according to race, region, and 
demographics. No significant association of hormone use with intermediate clinical 
outcomes among postmenopausal women who had recently suffered an acute coronary 
event was identified.
The results extend the randomized clinical trials into the acute setting and support 
the absence o f an indication for hormone use for secondary prevention o f atherosclerotic 
disease. The threat o f this study is found in the unmeasured confounding variables, 
including data collection methods that do not address comparisons between different
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agents, doses, routes, or length of administration o f hormones. The opportunity exists for 
future research on hormone replacement therapy in postmenopausal women.
According to Ridker, Hennekens, Buring, and Rifai (2000), in their data-based 
study indexed in MEDLINE, C-reactive protein was explored as a measure o f cardiac 
risk. In this prospective, nested case-control study o f 28,263 subjects, the additional 
concepts reviewed were lipid levels, women, and cardiovascular disease. Thirty-two 
references were cited. The large number of subjects was identified as a strength of the 
study. A weakness identified was the fact that only healthy postmenopausal women were 
studied for only a short period o f time. This threatens the results due to the possibility 
that findings may vary with longer time intervals. C-reactive protein (CRP) proved to be 
the strongest and most significant predictor o f  the risk o f fiiture cardiovascular (CV) 
events. Half o f the women studied who had cardiovascular events did not have overt 
hyperlipidemia. CRP should be added to standard lipid screening to improve methods for 
identifying persons at high risk for future CV events and thus become candidates for 
primary prevention interventions such as the use o f statins.
Schedlbauer, Schroeder, Peters and Fahey (2004), in a data-based inquiry cited in 
the Cochrane Library, examined the concepts of lipid lowering drugs, cardiovascular 
disease, and patient adherence. These randomized controlled trials included 5,942 
subjects and 128 references were reviewed by the authors. The large number o f subjects 
was identified as a definite strength of the study. The short follow-up of only 2 - 2 4  
months and the lack of a valid method for measuring adherence were identified 
weaknesses. The majority o f studies did not increase adherence significantly by 
informing, reminding, and motivating patients. Particular types o f interventions did not
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seem to be more effective than others. It is emphasized that adherence rates were 
extremely variable, which makes comparison between trials difficult. Despite efforts to 
increase the use o f lipid lowering medication and despite the fact that poor adherence to 
medication is common, randomized controlled trials in this area are limited in both 
number and quality. At this stage, no adherence-enhancing intervention can be 
recommended in clinical practice. The opportunity for further research to address 
adherence with a more patient-centered approach is needed. This would alleviate the 
threat o f the possibly skewed or unreliable data due to the substantial heterogeneity 
between these trials.
In a systematic literature review by Tecce, Dasgupta, and Doherty (2003), 
indexed in the Cochrane Library, several concepts were analyzed. The concepts o f this 
data-based study included heart disease, older women, gender differences, diagnosis, 
treatment and risk factors. Forty-four references were cited by the authors. The strength 
of this study is the identification o f gender differences in the diagnosis and treatment of 
cardiovascular disease. The merged subject data is an identified weakness. The literature 
selection methodology could account for skewed data therefore presenting a threat to the 
findings. Key findings include that women and men are equally susceptible to 
cardiovascular disease and its associated mortality and morbidity, yet women may not be 
offered invasive strategies as fi-equently as their male counterparts. The presentation of 
cardiovascular disease differs in men and women, therefore clinicians must be aware of 
these differences in order to achieve early diagnosis. Risk factor modification is 
imperative. Therapy must be individualized. This study provides a foundation for further 
research regarding gender differences in cardiovascular disease.
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According to Vega (2001), indexed in both MEDLINE and CINAHL, the 
concepts of hormone replacement therapy, menopause, postmenopausal women, 
cardiovascular prevention and coronary heart disease were reviewed. The author o f this 
data-based study reviewed 72 references that included 513 subjects in this systematic 
literature review. A strength o f the study was the large number of observational studies. 
The weakness identified was that the study was limited to only one specific treatment 
regimen for secondary prevention. The threat o f this research is that the results o f the 
observations and the randomized controlled trials do not match, and too much emphasis 
is being placed on the observations. Further research using randomized clinical trials is 
imperative to alleviate these discrepancies.
Observational studies associating estrogen therapy vdth or without an 
added progestin have consistently and strongly suggested an impressive risk reduction o f 
cardiovascular disease among postmenopausal women. The cardioprotective effects o f 
estrogen are explained by several plausible mechanisms. These claims are still considered 
inconclusive because of lack of data from large clinical trials to support them. The only 
RCT done showed HRTs had no overall cardiovascular benefit. For now the wisest 
course is to recommend the alternative interventions that have been proven by clinical 
trials supporting their effectiveness in reducing adverse cardiac events.
In a retrospective meta-analysis by Whitney et al. (2004), indexed in CINAHL, 
several concepts were examined. These concepts involved cardiovascular disease, 
osteoporosis, statins, physical activity, and postmenopausal women. The extensive 
reference list that included 176 articles is identified as a major strength o f the study. The 
heterogeneity o f trials represents a weakness. This literature selection methodology could
17
account for skewed findings that threaten the study. The researcher found that although 
mounting evidence supports a link between bone and CV health, it is unclear which of 
these conditions initiates the disease process and how each condition affects the other. It 
also remains to be determined if  exercise provides a synergistic effect with statins (or 
other medication) and additional health benefits. Further research will contribute to the 
limited body of knowledge and may have implications for future therapeutic targets, 
screening, prevention and cost-effective treatment of atherosclerosis, heart disease, and 
osteoporosis.
Summary
A review o f the literature reveals that cardiovascular disease in postmenopausal 
women is clearly a significant issue both due to the mortality and morbidity o f the 
disease, as well as to the prevalence in the U.S. The money spent annually on treatment 
o f CVD could instead be used for prevention of the devastating CVD events. Gender 
differences are well documented, and although gender is non-modifiable, education for 
both women and their healthcare providers regarding the discrepancies is imperative.
HRT is recommended only for the treatment o f hot flashes, insomnia and other symptoms 
of menopause, not for CVD protection. Despite the potential cardioprotective and 
osteoporosis effects of HRT, there is also evidence of detrimental effects o f this therapy 
in CVD. The risks and benefits o f HRT should be discussed with the patient prior to 
initiation for any purpose. Family history of early MI is a significant risk factor that also 
is non-modifiable.
The obvious focus must be on the modifiable risk factors for the prevention and 
treatment of CVD. Hyperlipidemia and hypertension may be controlled by a combination
18
o f appropriate diet, exercise, smoking cessation and medication. Diabetes and obesity are 
both treated with the combination o f diet, exercise and medication. Alcohol intake should 
be limited to one or less drinks per day. Exercise should be a minimum of 30 minutes o f 
brisk walking per day. Eighty-one mg o f  aspirin per day should be taken unless 
contraindicated. These recommendations along with the appropriate medications needed 
for each specific category of CVD will promote the optimum level o f  health for 
postmenopausal women with CVD.
CHAPTER III 
Design and Methodology
This study explores the literature regarding cardiovascular disease in 
postmenopausal women, the evidence-based practice guidelines, and the nurse 
practitioners role in the disease management. This chapter will present the specific 
parameters proposed for this research investigation. It will establish the approach, 
literature selection procedure, and literature analysis procedure.
Approach
An integrated literature review, which is a review o f research that combines 
comprehensive information on a topic, weighs pieces o f evidence, and integrates 
information to draw conclusions about the state o f knowledge, will be used for this 
project. This investigation is an evidence-based practice systematic review. While an 
integrative literature review summarizes research on a topic o f interest, by placing the 
research problem in context and identifying gaps and weaknesses in prior studies to 
justify the new investigation (Polit & Peck, 2004), evidence-based practice seeks to 
integrate best research evidence with clinical expertise and patient values (Straus, 
Richardson, Glasziou, & Haynes, 2005). A summary of the current literature regarding 
cardiovascular disease in postmenopausal women is provided.
Literature Selection Procedure
CINAHL, MEDLINE, and the COCHRANE Library were searched for literature 
regarding cardiovascular disease and postmenopausal women. Relevant literature was 
printed and reviewed for potential contributions to this investigation. The reference lists 
from these articles were manually searched and selected additional resources were
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retrieved from other reputable scholarly sources in the healthcare field. Article selection 
was based on inclusion of at least one o f the relevant concepts, whether as the focus of 
the article or as part o f a broader topic. Other informative articles were also included to 
further explore the knowledgebase.
The systematic review began with literature from CINAHL to  identify relevant 
nursing literature on cardiovascular disease in postmenopausal women. Next, both 
MEDLINE and the COCHRANE Library were searched for further relevant literature.
All articles were retrieved through the Mississippi University for Women Fant Library 
via internet databases. The review incorporated data beyond nursing literature to expand 
the knowledgebase for a thorough review, thus providing a multi-disciplinary approach.
Literature Analysis Procedure 
For the purposes of this study, the articles were selected then studied manually for 
their significant contribution to the investigation. They were separated into categories 
according to the particular aspect o f the research they addressed. The relevant issues 
include CVD statistics, gender differences, hormone replacement therapy, lipids, 
hypertension, diet, exercise, obesity, diabetes, smoking, osteoporosis and aspirin use. A 
knowledgebase of literature critiques developed by Dr. Janice Unruh Davidson (2003) 
was utilized to organize the literature by source and date, variables o f interest, literature 
type and research tools, research design and sample size, theoretical foundation, 
references, and key findings (see Appendix A). Data was then analyzed for relevancy o f 
findings and summarized utilizing the template format to assist in application of findings 
to the clinical problem. These findings represent the current state o f knowledge available
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that is discussed in Chapter Four according to the research questions regarding 
cardiovascular disease in postmenopausal women and its management.
Summary
This chapter presented the data-based research approach. Techniques for literature 
selection and literature analysis have been described. This investigation will allow 
healthcare providers to identify areas related to further research in understanding and 
managing cardiovascular disease in postmenopausal women.
CHAPTER IV 
Knowledgebase Findings and Practice-Based Application
The purpose of this chapter is to present the findings of the knowledgebase that 
was derived from this evidence-based systematic literature review regarding 
cardiovascular disease in postmenopausal women. Pertinent findings o f this study are 
provided with practice-based applications from current clinical practice guidelines.
A systematic literature search o f CINAHL, MEDLINE, and the COCHRANE 
Library was conducted by this author in order to obtain the knowledgebase findings. A 
total o f 13 citations were reviewed with an additional 611 references represented. 
Findings from the literature reviewed are addressed in this section in terms of each 
research question generated for the scope o f this study.
Research Question One
Research question one asks: “What is the level o f nursing knowledge regarding 
cardiovascular disease in postmenopausal women?” Based on the articles reviewed and 
found relevant to the above question, the level o f nursing knowledge regarding 
cardiovascular disease in postmenopausal women is quite broad. There is a massive 
number of studies related to the occurrence, presentation, diagnosis, treatment and 
outcomes o f women with cardiovascular disease. More research is needed, however, 
regarding such concepts as the usefulness o f c-reactive protein and homocysteine levels 
as increased risk factors.
Research Question Two
Research question two asks: “What are the evidence-based practice guidelines for 
cardiovascular healthcare of postmenopausal women?” Each o f the articles reviewed
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provided recommendations including management o f hypertension, lipid levels, exercise, 
hormone replacement, smoking cessation, and diet. These recommendations are listed in 
Table 3 below.
Table 3
Evidence-Based Recommendations-Lifestyle Factors_______________________ _
Lifestyle Factors Goals Recommendations
Smoking Complete cessation 
Avoid passive smoke
Encourage cessation each visit 
Reinforce nonsmoking status 
Provide counseling and 
pharmacotherapy
Physical activity At least 30min. daily o f 
moderate exercise
Incorporate physical activity into 
daily activities 
Cardiac rehab program for women 
with recent CV events
Nutrition AHA Step I Diet if  healthy 
AHA Step n  Diet in women 
with CVD 
Limit sodium chloride 
Increase fiber 
Consume 5 servings o f 
fruits/vegetables
Low saturated fat and high in fiber 
Drink skim milk 
Diets rich in antioxidants 
Limit alcohol to one glass/day
Weight Achieve/maintain desirable 
weight 
Target BMI 18.5-24.9 
Target waist < 35 inches
Gradual and sustained weight loss 
Dietary consult i f  needed
Psychosocial factors Decrease stress 
Improved quality o f life 
Maintain social support








R isk factors Goals Recom m endations
Blood pressure Below 140/90 Promote above lifestyle behaviors 
Pharmacotherapy for BP > 160/100, 
& 140/90 after 3 months o f 
lifestyle changes
Lipids Women s CVD:
L D L < 130  
Women c CVD
L D L < 100
H D L > 45
T G < 150
Above lifestyle changes 
Pharmacotherapy to maintain 
LDL, HDL, & TG
Diabetes FBS 80-120 
HS BS 100-140 
A 1 C < 7  
LDL < 100 
T G < 150  
Control BP
ADA diet
Low calorie diet pm  weight loss 
Regular physical activity 
Pharmacotherapy as indicated for BS
HRT Only if  benefits outweigh 
risks
Short-term for menopause 
symptoms pm
Individualize decision after risks 
& benefits discussed 
Progestin and estrogen combination 
if  uterus is intact
Anticoagulants Prevention of clots Use ASA 81mg if  not 
contraindicated
B-blockers Reduce reinfarction rate 
sudden death, & 
mortality p MI
Start within hours o f  evolving M l if  
not contraindicated and 
continue indefinitely
ACE inhibitors Reduce morbidity &
mortality p MI & 
c LV dysfunction
Start early unless hypotensive or 
contraindicated 
Continue indefinitely for LV
dysfunction, may stop in 6 
weeks otherwise
Mosca et al. (1999)
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Research Question Three
Research question three asks: “According to the literature, what is the role of the 
nurse practitioner in the management o f CVD in postmenopausal women?” None o f the 
articles reviewed addressed the role o f the nurse practitioner in the management o f CVD 
in postmenopausal women. The inclusive term, “healthcare provider” was used in 
addition to physician or “primary care provider”.
Summary
This chapter presents the findings o f a knowledgebase that was derived from an 
evidence-based literature review regarding cardiovascular disease in postmenopausal 
women. Pertinent findings were examined according to each of the three research 
questions addressed in Chapter I.
CHAPTER V
Evidence-Based Conclusions, Implications and Recommendations
The purpose o f this study was to investigate the current level o f nursing 
knowledge regarding cardiovascular disease in postmenopausal women. This chapter 
provides a summary of this investigation, including interpretations of the findings and the 
conclusions drawn from these results, as well as the limitations o f the study, and 
recommendations for future nursing research.
Summary o f  the Investigation
The purpose o f this investigation was to examine the current level o f nursing 
knowledge regarding cardiovascular disease in postmenopausal women utilizing Nola J. 
Pender’s Health Promotion Model. This model (Appendix B) served as the logical 
theoretical approach for this research due to the importance o f health promotion in the 
management o f CVD in postmenopausal women. The course o f this investigation was 
guided by three research questions. An extensive search o f CINAHL, MEDLINE, and the 
COCHRANE Library followed by the review o f 13 relevant articles provided the 
information summarized in chapter two. There was limited research regarding the role of 
the nurse practitioner in the management o f CVD in postmenopausal women except 
under the general term o f primary care provider. Implications for nursing theory, nursing 
research, advanced nursing practice, nurse practitioner education and health policy are 
identified.
Interpretation o f  Findings with Conclusions
According to the literature analysis, a great deal o f research is available regarding 
the occurrence, presentation, diagnosis, treatment, and outcomes of CVD in
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postmenopausal women. More study is needed, however, regarding additional 
inflammatory markers such as c-reactive protein and homocysteine levels and their 
significance as risk factors. This author has attempted in this investigation to consolidate 
the current information available regarding CVD in postmenopausal women.
Research Question One
Research question one asks: “What is the level of nursing knowledge regarding 
CVD in postmenopausal women?” A vast amount of knowledge exists regarding the 
occurrence, presentation, diagnosis, treatment, and outcomes of CVD in postmenopausal 
women, however further research is needed regarding the significance of additional 
cardiac markers and the effectiveness o f newly developed pharmacotherapeutics. 
Research Question Two
Research question two asks: “What are the evidence-based practice guidelines for 
cardiovascular healthcare o f postmenopausal women?” The literature reveals specific 
evidence-based guidelines as presented in tables 3 and 4. Most of these guidelines 
involve lifestyle factors such as smoking cessation, physical activity, nutrition, weight 
management, and psychosocial factors. The additional risk factors addressed are blood 
pressure control, lipid and diabetes management, anticoagulation, and 
pharmacotherapeutics.
Research Question Three
Research question three asks: “According to the literature, what is the role of the 
nurse practitioner in the management o f CVD in post menopausal women?” In the 
literature reviewed, the nurse practitioner role was not singled out specifically. The role 
o f the primary care provider o f which the nurse practitioner is included, however, was
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discussed at great lengths. The contribution o f the primary care provider in the 
management o f CVD in postmenopausal women is indisputable. Each healthcare 
encounter must include an assessment o f lifestyle factors that enhance the cardiovascular 
health o f the postmenopausal woman. The unique risk factors and presentation o f the 
disease in this population must be recognized by the nurse practitioner as well as taught 
to the patients and caregivers to enable early recognition o f symptoms. Pender’s Health 
Promotion Model aptly depicts the active role the nurse practitioner can have regarding 
the teaching and encouragement o f lifestyle changes.
Limitations
As discussed previously, one limitation identified in this study was the lack of 
published literature specifically related to the role o f the nurse practitioner in the 
management o f CVD in postmenopausal women. Only one of the articles reviewed 
specifically addressed this issue. An additional limitation was the potential for biased 
data due to the literature selection methodology utilized in this systematic review o f 
applicable research.
Implications and Recommendations
This investigation o f healthcare literature regarding CVD in postmenopausal 
women provided implications and recommendations focused on nursing theory, nursing 
research, advanced nursing practice, nurse practitioner education, and health policy. Each 
of the areas are presented in this section.
Nursing Theory
The theoretical foundation for this study was Nola J. Pender’s Health Promotion 
Model. This model clearly depicts the influence that the nurse practitioner can have
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regarding the adherence to the lifestyle modifications necessary for the cardiovascular 
health maintenance of postmenopausal women. This theory helps to guide further 
research into areas o f patient-provider relationships and the validation of evidence-based 
practice.
Nursing Research
Nursing research relates to a systematic method designed to develop knowledge 
about ideas o f interest to the nursing profession. A great deal of research exists describing 
certain concepts o f CVD in postmenopausal women. Research regarding the specific 
contribution of the nurse practitioner in this population with CVD is limited. This 
research serves to empower practice and enhance the status of nursing as a profession by 
expanding nursing’s scientific knowledgebase.
Advanced Nursing Practice
An advanced practice nurse (APN) is a registered nurse who through advanced 
training is qualified to assume some of the duties and responsibilities formerly only 
assumed by physicians. As a primary care provider, it is imperative for the APN to be 
knowledgeable o f the available research that exists regarding CVD in postmenopausal 
women. This knowledgebase will allow the foundation for the evidence-based practice 
guidelines to be incorporated by the APN. Prompt recognition of the unique 
characteristics o f CVD in this population as well as the management strategies are 
invaluable weapons in the APN’s arsenal.
Nurse Practitioner Education
This knowledgebase o f information regarding CVD in postmenopausal women 
must be incorporated into the education of all nurse practitioners. The knowledge is
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necessary for the transition o f the experienced nurse into the role o f a primary care 
provider. The findings of nursing research are useless if  the process does not include the 
dissemination o f the information to those whom it will benefit in practice.
Health Policy
A shift in health policy from treatment to wellness promotion has presented an 
open door for the nurse practitioner as a primary care provider. The majority o f 
physicians have traditionally chosen disease specialties rather than the wellness 
promotion of primary care as their focus. This opportunity challenges nurse practitioners 
to stay abreast o f the latest research and trends in health policy.
Summary
This chapter presented the evidence-based conclusions, implications, and 
recommendations that were derived from this systematic literature review. Implications 
and recommendations for nursing theory, nursing research, advanced nursing practice, 
nurse practitioner education, and health policy were provided as they emerged from the 
concepts explored. The limitations identified as well as the interpretation of the findings 
were discussed.
The purpose o f this Evidence-Base Practice (EBP) project was to develop an 
advanced practice nurse knowledgebase regarding cardiovascular disease in 
postmenopausal women. The research questions asked were as follow:
1. What is the level o f nursing knowledge regarding CVD in postmenopausal women?
2. What are the evidence-based practice guidelines for cardiovascular healthcare o f 
postmenopausal women?
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3. According to the literature, what is the role o f the nurse practitioner in the management 
o f CVD in postmenopausal women?
A Boolean computer search of nursing and medical literature utilizing CINAHL, 
MEDLINE, and the COCHRANE Library was conducted for this review. Pender’s 
Health Promotion Model served as the theoretical foundation for this clinical project and 
guided the systematic review through data collection of the healthcare literature. A 
knowledgebase was then developed utilizing the template developed by Davidson which 
captured the source and database, variables o f interest, literature type and research tools, 
research design and sample size, theoretical foundation, number of references, strengths, 
weaknesses, opportunities, threats and key findings of each of the articles reviewed. 
Evidence-based practice recommendations were presented and further nursing research 
was advised.
The overwhelming prominence o f cardiovascular disease in postmenopausal 
women presents a challenge to each nurse practitioner to stay current on research findings 
on the concept so that the best possible care can be provided to each patient. How could 
one teach what they do not know?
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